1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Rafina Innovations Inc.

Rafina Innovations Inc.

VICA
Rafina Innovations Inc.US flagOther OTC
0.00
USD
- -
- -
14,572.00Market Cap
Rafina Innovations Inc.
VICA
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
0.07
0.04
0.03
0.02
Revenue per Share
-0.09
-0.13
-0.03
-0.03
-0.02
-0.01
-1.08
-8.89
-1.22
-0.17
-0.3
-0.43
-0.4
Basic EPS, GAAP
-0.08
-0.13
-0.02
-0.03
-0.02
-0.02
-0.04
-0.28
-0.18
-0.05
-0.07
-0.07
-0.04
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.09
-0.21
-0.23
-0.26
-0.28
-0.29
-1.37
-9.68
-3.88
-3.3
-3.49
-2.95
-2.88
Book Value per Share
-0.06
-0.08
-0.11
-0.14
-0.15
- -
-1.07
-0.01
-0.16
-0.11
-0.09
-0.04
-0.04
Tangible Book Value per Share
1
1
1
1
1
1
1
2
8
10
10
14
14
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
-11,506.65
-12,071.3
-233.56
-810.29
-1,026.55
-1,241.49
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
-1
-19
-9
-2
-3
-6
-6
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
-70,275.52
-15,695.45
-232.19
-839.79
-1,417.52
-1,723.97
Profit Margin (%)
- -
- -
- -
- -
- -
- -
-1
- -
-1
-1
-1
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
-1
- -
-1
-1
-1
- -
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'18
Dec'18
Mar'19
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
16
16
Market Capitalization
2
1
- -

Working Capital

FRC

•

in mil. unless spec.
Sep'18
Dec'18
Mar'19
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2,912.3%
1,203.05%
-45.75%
Free Cash Flow
117.39%
227.11%
24.15%
Net Income, GAAP
1,095.08%
274.04%
95.82%
Sales/Revenue/Turnover
- -
- -
16.01%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
-0.08
-0.03
-0.05
- -
-0.3
2018
-0.06
-0.17
-0.03
- -
-0.43
2019
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
Similar Companies
Align Technology, Inc. (0HCK.L)
SofWave Medical Ltd. (SOFW.TA)
Shenzhen Edge Medical Co Ltd (2675.HK)
Hamilton Thorne Ltd. (HTLZF)
Elbit Imaging Ltd. (EMITF-M.TA)
SomnoMed Limited (SOM.AX)
Business
Rafina Innovations Inc. Rafina Innovations Inc. (VICA) engages in the research, development, commercialization, and marketing of medical technologies, with a focus on prosthetics, orthotics, rehabilitation, and related biomedical fields. The company operates through two primary segments, Clinics and Technology; the Clinics segment provides prosthetics and orthotics services along with diabetic foot total rehabilitation clinics, while the Technology segment develops and sells medical devices including Flexisense sensing technology, smart insoles, and products in bioengineering, mobility, diabetes management, tissue mechanics, ultrasonics, medical signal processing, orthopedics, and robotic surgery. It serves patients and healthcare providers primarily through clinics in Southern Europe, the Middle East, and North Africa, with additional licensing of proprietary technologies targeting Euro-Asia pharmaceutical distribution. Founded in 2007 and headquartered in Glasgow, United Kingdom, Rafina Innovations Inc. changed its name from HCi Viocare in July 2018 to reflect its expanded focus on innovation in medical technologies. In April 2021, the company completed the 100% acquisition of C-PHARM Ltd, a wholesale licensed pharmaceutical firm specializing in the import, testing, and distribution of active pharmaceutical ingredients (API) products across Euro-Asia territories, enhancing its operational capabilities and purchasing power for pharmaceutical supplies. This strategic move supports expansion of clinic operations and technology commercialization, including ongoing development of biomedical devices like sleep apnea prototypes and Flexisense applications.

Company News

APIChatGPT

  • accesswire.com

    OPTEC International Acquires Controlling Interest of Rafina Innovations

  • globenewswire.com

    Rafina's Subsidiary C-Pharm Ltd Revenues for First Quarter 2021 $1.7 Million

  • globenewswire.com

    Rafina Innovations Inc. Announces Brand-New Website and Exclusive Distributor Agreement with OPTEC International Inc.